Tyrosine kinase inhibitors of Ripk2 attenuate bacterial cell wall-mediated lipolysis, inflammation and dysglycemia
Brittany M. Duggan(McMaster University), Jonathan D. Schertzer(McMaster University)
Cited by 39
Related Papers
NOD1 Activators Link Innate Immunity to Insulin Resistance
|Diabetes|2011|247
Bacterial Peptidoglycan Stimulates Adipocyte Lipolysis via NOD1
|PLoS ONE|2014|77